Spinal Tech

Vexim has sold 25,000 SpineJack units since the product's market launch in 2011.

Medtech has made eight new sales of its ROSA robot during its fiscal second quarter 2016.

The FDA has approved the PMA Supplement for Integra LifeSciences' Dermal Regeneration Template.

InVivoLink appointed John Bass CEO.

Medtech received 510(k) clearance from the FDA to market the ROSA Spine robot in the United States.

A fire at an Indiana Zimmer Biomet plant on Jan. 5 was contained and no injuries were reported, according to a Journal-Gazette report.

Agent Medical launched two new lower extremity products.

Benvenue Medical completed a $60 million round of financing.

The FDA approved a protocol amendment for InVivo's ongoing pilot INSPIRE study, making it a pivotal probable benefit study.

Medtronic CEO Omar Ishrak offers his opinion on whether Google could become a competitor or an ally.